Is there a causal relationship between autoimmune diseases and oropharyngeal cancer?

Abstract

Background: Autoimmune diseases (AIDs) are linked to oropharyngeal cancer (OPC), but the exact nature of this association remains unclear. This study aims to examine the potential causal effect of AIDs on the risk of developing OPC. Method: Information regarding AIDs was collected from the UK Biobank dataset and the Finn Gen study. OPC data were sourced from the IEU Open GWAS project. All data were derived from European populations. Inverse variance weighted (IVW) to two-sample Mendelian randomization (MR) was complemented by weighted median and MR Egger validation analyses. Result: The development of asthma (AS), multiple sclerosis (MS), and rheumatoid arthritis (RA) influenced the risk of developing OPC. However, the reverse MR analysis did not provide evidence for the impact of OPC on AIDs. Sensitivity analysis using MR corroborated the IVW results. The IVW results indicate OR values of 1.004 for AS, 0.936 for MS, and 1.0002 for RA. Conclusion: This MR study supports a causal relationship between asthma and rheumatoid arthritis for OPC in a European population. Multiple sclerosis was protective against OPC.

Keywords

Causality Mendelian randomization Oropharyngeal cancer Autoimmune diseases

Get full access to this article

View all access options for this article.

References

Adams

S.M.

Bornemann

P.H.

(2013): Ulcerative colitis. American Family Physician 87, 699-705

Bahar

Yildiz

Bahar

A.R.

Karabudak

(2023): Is cancer risk reduced in multiple sclerosis? Results from a tertiary referral center. Turkish Journal of Medical Sciences 53, 962–969.

Batista

N.V.R.

Valdez

R.M.A.

Silva

E.M.V.M.

Melo

T.S.

Pereira

J.R.D.

Warnakulasuriya

(2023): Association between autoimmune rheumatic diseases and head and neck cancer: Systematic review and meta-analysis. Journal of Oral Pathology & Medicine 52, 357-364.

Bjornevik

Cortese

Healy

B.C.

Kuhle

Mina

M.J.

Leng

(2022): Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296-301.

Boehncke

W.H.

Schon

M.P.

(2015): Psoriasis. The Lancet 386, 983-994.

Chaturvedi

A.K.

Engels

E.A.

Pfeiffer

R.M.

Hernandez

B.Y.

Xiao

Kim

, (2023): Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States. Journal of Clinical Oncology 41, 3081-3088.

Cordtz

Mellemkjaer

Glintborg

Hetland

M.L.

Madsen

O.R.

Jensen, Hansen

I.M.

Dreyer

(2016): Risk of virus-associated cancer in female arthritis patients treated with biological DMARDs-a cohort study. Rheumatology (Oxford) 55, 1017-1022.

Coussens

L.M.

Werb

(2002): Inflammation and cancer. Nature 420, 860-867.

Davies

N.M.

Holmes

M.V.

and Davey, Smith, G. (2018): Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. British Medical Journal 362, k601.

10.

Ference

B.A.

(2022): Interpreting the Clinical Implications of Drug-Target Mendelian Randomization Studies. Journal of the American College of Cardiology 80, 663-665.

11.

Franks

A.L.

Slansky

J.E.

(2012): Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Research 32, 1119-1136.

12.

Guan

Sturgis

E.M.

Lei

Liu

Dahlstrom

K.R.

Wei

(2010): Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clinical Cancer Research 16, 1416-1422.

13.

Guidry

J.T.

Birdwell

C.E.

Scott

R.S.

(2018): Epstein-Barr virus in the pathogenesis of oral cancers. Oral Diseases 24, 497-508.

14.

Hellevik

A.I.

Asvold

B.O.

Bjoro

Romundstad

P.R.

Nilsen

T.I.

Vatten

L.J.

(2009): Thyroid function and cancer risk: a prospective population study. Cancer Epidemiology, Biomarkers & Prevention 18, 570-574.

15.

Karin

(2006): Nuclear factor-kappaB in cancer development and progression. Nature 441, 431-436.

16.

Katsanos

K.H.

Roda

McBride

R.B.

Cohen

Colombel

J.F.

(2016): Increased Risk of Oral Cancer in Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 14, 413-420.

17.

Kishimoto

Komine

Sashikawa-Kimura

Ansary

T.M.

Kamiya

Sugai

(2021): STAT3 Activation in Psoriasis and Cancers. Diagnostics (Basel) 11 (10).

18.

Kurki

M.I

Karjalainen

Palta

Sipilä

T.P.

Kristiansson

Donner

K.M.

(2023): FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508-518.

19.

Langdon

Richmond

Elliott

H.R.

Dudding

Kazmi

Penfold

(2020): Identifying epigenetic biomarkers of established prognostic factors and survival in a clinical cohort of individuals with oropharyngeal cancer. Clinical Epigenetics 12, 95.

20.

Lawlor

D.A.

Harbord

R.M.

Sterne

J.A.

Timpson

Davey Smith

(2008): Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Statistics in Medicine 27, 1133-1163.

21.

Lechner

Liu

Masterson

Fenton

T.R.

(2022): HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nature Reviews Clinical Oncology 19, 306-327.

22.

Lin

Xiao

Guo

Tian

Yun

Chen

(2015): Chronic inflammation-related DNA damage response: a driving force of gastric cardia carcinogenesis. Oncotarget 6, 2856-2864.

23.

Mandl

L.A.

(2019): Osteoarthritis year in review 2018: clinical. Osteoarthritis Cartilage 27, 359-364.

24.

Marcus

(2022): What Is Multiple Sclerosis? Journal of the American Medical Association 328, 2078.

25.

Massague

and

Sheppard

, D. (2023): TGF-beta signaling in health and disease. Cell 186, 4007-4037.

26.

Migliaro

Massuh

Infante

M.F.

Brahm

A.M.

San

Martin

and Ortuno

M.T.

, D. (2022): Role of Epstein-Barr Virus and Human Papilloma Virus in the Development of Oropharyngeal Cancer: A Literature Review. International Journal of Dentistry 2022, 3191569.

27.

Mills

K.H.

McGuirk

(2004): Antigen-specific regulatory T cells--their induction and role in infection. Seminars in Immunology 16, 107-117.

28.

Multhoff

Molls

Radons

(2011): Chronic inflammation in cancer development. Frontiers in Immunology 2, 98.

29.

Papadimitriou

Dimou

Tsilidis

K.K.

Banbury

Martin

R.M.

Lewis

(2020): Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nature Communications 11, 597.

30.

Patel

S.L.

Prakash

Gupta

(2020): TGF-beta1 +869C/T polymorphism increases susceptibility to rheumatoid arthritis in North Indian population. Clinical Rheumatology 39, 2881-2888.

31.

Bao

Wang

Ding

(2023): Mendelian randomization eradicates the causal relationship between educational attainment, household income, and oropharyngeal cancer. Frontiers in Oncology 13, 930940.

32.

Sekula

Del Greco

M.F.

Pattaro

Kottgen

(2016): Mendelian Randomization as an Approach to Assess Causality Using Observational Data. Journal of the American Society of Nephrology 27, 3253-3265.

33.

Skrivankova

V.W.

Richmond

R.C.

Woolf

B.A.R.

Yarmolinsky

Davies

N.M.

Swanson

S.A.

(2021): Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. Journal of the American Medical Association 326, 1614-1621.

34.

Soldan

S.S.

Lieberman

P.M.

(2023): Epstein-Barr virus and multiple sclerosis. Nature Reviews Microbiology 21, 51-64.

35.

Stojanovich

Marisavljevich

(2008): Stress as a trigger of autoimmune disease. Autoimmunity Reviews 7, 209-213.

36.

Turunen

Rautava

Grenman

Syrjänen

(2017): Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas. Oncotarget 8, 27328-27338.

37.

Woo

Lee

S.W.

Koh

H.Y.

Kim

M.A.

Han

M.Y.

Yon

D.K.

(2021): Incidence of cancer after asthma development: 2 independent population-based cohort studies. Journal of Allergy and Clinical Immunology 147, 135-143.

38.

Zhou

Liu

Yang

Zhou

Zhao

Chen

(2022): The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China. Cancer Communications 42, 435-446.